Does consistent piperacillin dosing result in consistent therapeutic concentrations in critically ill patients? A longitudinal study over an entire antibiotic course

International Journal of Antimicrobial Agents

Volumn 43, Issue 5, 2014, Pages 470-473

  Carlier, Mieke ^a,b   Carrette, Sofie ^b   Stove, Veronique ^b   Verstraete, Alain G ^a,b   De Waele, Jan J ^b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Biological variation; ICU; PK PD; TDM; Lactams

Indexed keywords

CREATININE; PIPERACILLIN; ANTIINFECTIVE AGENT;

ADULT; AGED; APACHE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; FEMALE; HUMAN; LOADING DRUG DOSE; LONGITUDINAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TANDEM MASS SPECTROMETRY; TREATMENT DURATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ADOLESCENT; CHEMISTRY; COHORT ANALYSIS; CRITICAL ILLNESS; DRUG EFFECTS; INTENSIVE CARE; LIQUID CHROMATOGRAPHY; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; PLASMA; PROCEDURES; PROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE; LONGITUDINAL STUDIES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PIPERACILLIN; PLASMA; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84899556727     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.01.028     Document Type: Article

References (15)

1. R.P. Dellinger, M.M. Levy, A. Rhodes, D. Annane, H. Gerlach, and S.M. Opal et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 Intens Care Med 39 2013 165 228
2. F.S. Taccone, P.F. Laterre, T. Dugernier, H. Spapen, I. Delattre, and X. Wittebole et al. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock Crit Care 14 2010 R126
3. A.A. Udy, J.M. Varghese, M. Altukroni, S. Briscoe, B.C. McWhinney, and J.P. Ungerer et al. Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations Chest 142 2012 30 39
4. J.A. Roberts, and J. Lipman Pharmacokinetic issues for antibiotics in the critically ill patient Crit Care Med 37 2009 840 851
5. M. Carlier, S. Carrette, J. Roberts, V. Stove, A. Verstraete, and E. Hoste et al. Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used? Crit Care 17 2013 R84
6. V. Stove, E. Van de Velde, M. Carlier, and A. Verstraete A UPLC-MS/MS assay for the quantification of meropenem and piperacillin concentrations in human plasma 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology 2-6 October 2011, Stuttgart, Germany. 2011 International Association of Therapeutic Drug Monitoring and Clinical Toxicology Kingston, Ontario, Canada
7. European Committee on Antimicrobial Susceptibility Testing Antimicrobial wild type distributions of microorganisms 2012 EUCAST http://mic.eucast.org/ Eucast2/SearchController/search.jsp?action=init [accessed 30.03.12]
8. J.A. Roberts, M. Ulldemolins, M.S. Roberts, B. McWhinney, J. Ungerer, and D.L. Paterson et al. Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept Int J Antimicrob Agents 36 2010 332 339
9. M. Hites, F.S. Taccone, F. Wolff, F. Cotton, M. Beumier, and D. De Backer et al. Case-control study of drug monitoring of β-lactams in obese critically ill patients Antimicrob Agents Chemother 57 2013 708 715
10. Y. Hayashi, J. Lipman, A.A. Udy, M. Ng, B. McWhinney, and J. Ungerer et al. β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia Int J Antimicrob Agents 41 2013 162 166
11. A. Udy, J. Roberts, A. Shorr, R. Boots, and J. Lipman Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients Crit Care 17 2013 R35
12. U. Tröger, A. Drust, J. Martens-Lobenhoffer, I. Tanev, R.C. Braun-Dullaeus, and S.M. Bode-Böger Decreased meropenem levels in intensive care unit patients with augmented renal clearance: benefit of therapeutic drug monitoring Int J Antimicrob Agents 40 2012 370 372
13. A.A. Udy, M.T. Putt, S. Shanmugathasan, J.A. Roberts, and J. Lipman Augmented renal clearance in the intensive care unit: an illustrative case series Int J Antimicrob Agents 35 2010 606 608
14. F.S. Taccone, F. Cotton, S. Roisin, J.-L. Vincent, and F. Jacobs Optimal meropenem concentrations to treat multidrug-resistant Pseudomonas aeruginosa septic shock Antimicrob Agents Chemother 56 2012 2129 2131
15. G. Wong, S. Briscoe, S. Adnan, B. McWhinney, J. Ungerer, and J. Lipman et al. Protein binding of β-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations? Antimicrob Agents Chemother 57 2013 6165 6170